Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
Dividend
|
Expensive Performer
586.7500
-23.95
(
-3.92
%)
NSE
May 08, 2025
15:31 PM
52.22% Gain from 52W Low
Volume:
2.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
05 Dec 2016
Dividend
586.75
-3.92%
IPO Note - Laurus Labs Ltd
ipo note:
Laurus Labs Ltd.
by
Aditya Birla Money Limited
Aditya Birla Money Limited
Laurus Labs Ltd. has an
average target
of 633.50 from 4 brokers.
More from Laurus Labs Ltd.
Recommended
Market closes lower, Asian Paints' Q4 revenue misses Forecaster estimates by 3.5%
Trendlyne Marketwatch |
08 May 2025, 04:03PM
Superstar investor portfolios take a hit from market volatility | Screener: Promoters reducing their stakes
The Baseline |
08 May 2025, 12:37AM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020